The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Tumors in Rubinstein‐Taybi syndrome
Abstract
The 14 tumors reported in Rubinstein‐Taybi syndrome since 1989, when added to the 22 previously reported, are beginning to show a pattern of neural and developmental tumors, especially of the head, which is malformed in the syndrome. Among the neoplasms were 12 of the nervous system: 2 each of oligodendroglioma, medulloblastoma, neuroblastoma, and benign meningioma, a pheochromocytoma, and 3 other benign tumors; 2 of nasopharyngeal rhabdomyo‐sarcoma; and 1 each of leiomyosarcoma, seminoma, and embryonal carcinoma. Among the other benign tumors were an odontoma, a choristoma, a dermoid cyst, and 2 pilomatrixomas. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Self-citationBloom Syndrome: A Mendelian Prototype of Somatic Mutational Disease
German, J. (1993) · Medicine · doi:10.1097/00005792-199311000-00003 · Cited by 593
A performance status scale for head and neck cancer patients
List, M. A., Ritter-Sterr, C., & Lansky, S. B. (1990) · Cancer · doi:10.1002/1097-0142(19900801)66:3<604::aid-cncr2820660334>3.0.co;2-l · Cited by 529
Malignancy in Neurofibromatosis
S�rensen, S. A., Mulvihill, J. J., & Nielsen, A. (2015) · Familial Cancer · doi:10.1159/000412547 · Cited by 267
Rubinstein-Taybi syndrome in the Netherlands
Hennekam, R. C. M., van den Boogaard, M. H., Sibbles, B. J., & Spijker, H. G. V. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370604 · Cited by 117
Ruymann, F. B., Maddux, H. R., Ragab, A. H., Soule, E. H., Palmer, N., Beltangady, M. S., Gehan, E. A., & Newton, W. A. (1988) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950160109 · Cited by 91
Cohen, B. H. (1992) · Neurology · doi:10.1212/wnl.42.12.2308-c · Cited by 89
Keloids and neoplasms in the Rubinstein‐Taybi syndrome
Siraganian, P. A., Rubinstein, J. H., & Miller, R. W. (1989) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950170526 · Cited by 82
Self-citationDeletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.
Hennekam, R. C. M., Tilanus, M. G. J., Hamel, B. C. J., Heeren, H. V.-V., Mariman, E. C. M., van Beersum, S. E. C., van den Boogaard, M. H., & Breuning, M. H. (1993) · Europe PMC (PubMed Central) · Cited by 68
Cited by
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
“As previously discussed, CPB and p300 have been proposed to be tumor suppressors and studies of RTS patients have suggested that these individuals may be at risk for developing certain types of cancer (Miller and Rubinstein 1995).”
BackgroundRubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
“Meanwhile, loss of another family member, p300, has also been associated with hematological malignancies.(179,180) Therefore, both CBP and p300 seem to function as tumor suppressors.”
BackgroundRosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
The world of protein acetylation
Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 804
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
Iyer, N. G., Özdag, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 638
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Protein Lysine Acetylation by p300/CBP
Dancy, B. M., & Cole, P. A. (2015) · Chemical Reviews · doi:10.1021/cr500452k · Cited by 609
CBP and p300: HATs for different occasions
Kalkhoven, E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.045 · Cited by 496
Roelfsema, J. H., White, S. J., Ariyürek, Y., Bartholdi, D., Niedrist, D., Papadia, F., Bacino, C. A., den Dunnen, J. T., van Ommen, G.-J. B., Breuning, M. H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429130 · Cited by 478
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T.-P. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 440
The Sonic Hedgehog–Patched–Gli Pathway in Human Development and Disease
Villavicencio, E. H., Walterhouse, D. O., & Iannaccone, P. M. (2000) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)62934-6 · Cited by 435
Evans, C. J., Hartenstein, V., & Banerjee, U. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00335-6 · Cited by 433
Roles of BCL6 in normal and transformed germinal center B cells
Basso, K., & Dalla‐Favera, R. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01112.x · Cited by 429
Conjunction dysfunction: CBP/p300 in human disease
Giles, R. H., Peters, D. J. M., & Breuning, M. H. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01438-3 · Cited by 403
Hennekam, R. C. M. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201594 · Cited by 320
Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley, J. D., & Zeleznik-Le, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8732 · Cited by 319
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Wilting, R. H., & Dannenberg, J.-H. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.008 · Cited by 303
CREB-binding protein and p300: molecular integrators of hematopoietic transcription
Blobel, G. A. (2000) · Blood · doi:10.1182/blood.v95.3.745.003k05_745_755 · Cited by 260
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 74
Epigenetic Mechanisms of Rubinstein–Taybi Syndrome
Park, E., Kim, Y., Ryu, H., Kowall, N. W., Lee, J., & Ryu, H. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8285-3 · Cited by 63
Metadata
- Authors
- Miller, R. W., & Rubinstein, J. H.
- Venue
- American Journal of Medical Genetics
- Publisher
- Wiley
- Published
- 1995-03-13
- Volume
- 56
- Issue
- 1
- Pages
- 112-115
- ISSN
- 0148-7299 (ISSN-L)
- 1096-8628
- OpenAlex
- W2120412844
- Cited by
- 283
- References
- 9
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.